课题基金 / 基金详情

Pharmacological preconditioning effect of isoflurane against renal ischemia/reperfusion injury in rats.

Pharmacological preconditioning effect of isoflurane against renal ischemia/reperfusion injury in rats.
异氟烷对大鼠肾缺血/再灌注损伤的药理预处理作用。
批准号:
14571448
负责人:
MOROOKA Hiroaki
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

MOROOKA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
异氟醚在心脏和大脑中具有药理预处理作用。在本研究中,我们对肾脏及其机制进行了探讨。将大鼠分为4组,每组8只。A、B组为假手术。C、D组双侧肾缺血40 min。B组和D组在假手术或缺血前给予1.5%异氟醚治疗20 min。分别于再灌注后12、24、48小时采血。血清肌酐和尿素氮在24和48 h时显著高于D组(p<0.01)。此外,在组织病理学检查中,可以看到异氟醚治疗对损伤的抑制。为探讨其作用机制,ⅰ组和ⅱ组分别给予单侧肾缺血40分钟。II组缺血前给予1.5%异氟醚治疗20 min。测定JNK、p38和ERK的活性。ⅱ组JNK、ERK活性显著低于ⅰ组(p<0.05)。综上所述,异氟醚在缺血前给药对肾缺血再灌注损伤具有预处理作用。蛋白激酶JNK和ERK的抑制可能参与了这一机制。
英文摘要
Isoflurane had a pharmacological preconditioning effect in the heart and brain. In this study, we investigated about the kidney and the mechanism. Rats were divided into four groups (n=8 for each). In groups A and B were sham surgery. Groups C and D were subjected to 40-min bilateral renal ischemia. Groups B and D received 1.5 % isoflurane for 20 min before sham surgery or ischemia. Blood sampling was performed at 12,24 and 48 hrs after reperfusion. The values of serum creatinine and blood urea nitrogen showed significant increases in group C compared to D at 24 and 48 hrs (p<0.01). Additionally in the histopathological examination, suppression of the damage was seen with the isoflurane treatment. To investigate the mechanism, group I and II were subjected to 40-min unilateral renal ischemia. Group II received 1.5 % isoflurane for 20 min before ischemia. The activities of JNK, p38 and ERK were measured. The activities of JNK and ERK in group II were significantly lower than those in group I (p<0.05). In conclusion, isoflurane shows preconditioning effect against renal ischemia/reperfusion injury when administered before ischemia. Inhibition of the protein kinases, JNK and ERK, might be involved in the mechanisms.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
The protective effect of isoflurane against renal ischemia/reperfusion injury in rats
异氟烷对大鼠肾缺血/再灌注损伤的保护作用
DOI: --
发表时间: 2003
期刊: Anesthesiology 96
影响因子: --
作者: [Yoshitomi O, Hara T, Akiyama D, Oshibuchi M, Sumikawa K, Hiroshi Miyoshi]
通讯作者: Hiroshi Miyoshi
DOI: 10.1213/01.ane.0000130650.47552.18
发表时间: 2004-09-01
期刊: ANESTHESIA AND ANALGESIA
影响因子: 5.7
作者: [Todoroki, S, Morooka, H, Sumikawa, K]
通讯作者: Sumikawa, K
Isoflurane inhibits NFkB activation in response to simulated ischemia in renal tubular cell line, LLC-PK1
异氟烷抑制肾小管细胞系 LLC-PK1 模拟缺血时 NFkB 的激活
DOI: --
发表时间: 2003
期刊: Anesthesiology 99
影响因子: --
作者: [Yoshitomi O, Hara T, Akiyama D, Oshibuchi M, Sumikawa K, Hiroshi Miyoshi, Hiroaki Murata, Sungsam Cho, Guao Huan, Sungsam Cho, Masanori Matsumoto]
通讯作者: Masanori Matsumoto
Masanori Matsumoto, Hiroaki Morooka, et al.: "Isoflurane inhibits NFkB activation in response to simulated ischemia in renal tubular cell line, LLC-PK1"Anesthesiology. 99. A1545 (2003)
Masanori Matsumoto、Hiroaki Morooka 等人:“异氟烷抑制 NFkB 激活以响应肾小管细胞系 LLC-PK1 中的模拟缺血”麻醉学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 9 条
    Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK.
    • 批准号:
      15591639
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      2003
    • 负责人:
      MOROOKA Hiroaki
    • 依托单位:
    N-acetyl-L-cysteine inhibits activitation of p38 MAP kinase in heat stressed heart
    • 批准号:
      11671507
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      1999
    • 负责人:
      MOROOKA Hiroaki
    • 依托单位:
    国内基金
    海外基金
    丁酸通过抑制p38/ERK/JNK信号通路重建Treg/Th17平衡缓解艰难梭菌结肠炎的机制研究
    circFOXM1通过CTCF/TP53轴调控糖酵解与JNK通路诱导胶质瘤替莫唑胺耐药的机制与转化研究
    • 批准号:
      2026JJ82323
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚勇
    • 依托单位:
    DUSP10通过抑制JNK/P38延缓肾脏缺血再灌注纤维化的关键机制研究
    • 批准号:
      2026JJ50647
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      郭勇
    • 依托单位:
    CDH5介导p38/JNK通路调控糖尿病视网膜病变的分子机制及干预探索
    • 批准号:
      2026JJ80392
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王桂芳
    • 依托单位: